Latanoprost/Timolol Olikla

Timolol maleate and latanoprost, the active ingredient in Latanoprost/Timolol Olikla, is a beta‑blocker and prostaglandin analog presented as eye drops for ocular use. It treats open‑angle glaucoma and ocular hypertension in adults.

GNH USA supplies Latanoprost/Timolol Olikla as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Latanoprost/Timolol Olikla is used in the management of ocular conditions that require reduction of intra‑ocular pressure.

- Open‑angle glaucoma: lowers intra‑ocular pressure to prevent optic nerve damage. - Ocular hypertension: reduces pressure to decrease risk of developing glaucoma. - Secondary glaucoma (e.g., pseudoexfoliative): helps control pressure when other therapies are insufficient.

The following adverse reactions have been reported with Latanoprost/Timolol Olikla.

Common Side Effects: - Eye irritation or burning sensation. - Blurred vision. - Redness of the conjunctiva. - Itching or mild allergic response. - Dry eye or foreign body sensation. - Temporary changes in eyelash growth.

Serious or Rare Side Effects: - Severe allergic reaction (angioedema, anaphylaxis). - Significant increase in intra‑ocular pressure. - Corneal ulcer or keratitis. - Vision loss or sudden visual disturbances. - Systemic beta‑blocker effects such as bradycardia, hypotension, or bronchospasm. - Persistent eye pain or photophobia.

Before using Latanoprost/Timolol Olikla, consider the following precautions.

- Pregnancy: consult a healthcare professional before use. - Breastfeeding: discuss potential risks with a physician. - Asthma or COPD: avoid due to possible bronchoconstriction from timolol. - Cardiac disease: monitor heart rate and blood pressure closely. - Severe ocular surface disease: use with caution as irritation may worsen. - Contact lens wearers: remove lenses before instillation and wait before reinserting. - Store at room temperature: keep in the original container, protect from light and moisture.

Latanoprost/Timolol Olikla may interact with other medications.

Major Interactions (Avoid): - Other ocular beta‑blockers (additive systemic beta‑blockade). - Systemic non‑selective beta‑blockers (risk of bradycardia, hypotension). - Concurrent prostaglandin analogs (increased risk of ocular side effects).

Moderate Interactions (Monitor Closely): - Antihistamine eye drops (potential for reduced efficacy). - Topical NSAIDs (may increase ocular irritation). - Alpha‑adrenergic agonists (possible antagonistic effect on pressure reduction). - Carbonic anhydrase inhibitors (monitor intra‑ocular pressure for additive effect).